Home

Market Capitalization of Gujarat Themis Biosyn Ltd

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

Market Cap

₹ 2663.11 crore

Last updated on: Feb 21, 2025

Key Highlights

  • The Market Cap of Gujarat Themis Biosyn Ltd is ₹ 2663 crore as of 21 Feb 25 .
  • The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 244.4 as of 21 Feb 15:30 .
  • The Dividend Payouts of Gujarat Themis Biosyn Ltd changed from ₹ 2 on Nov 24, 2021 to ₹ 0.25 on Jul 15, 2024 . This represents a CAGR of -29.29% over 6 years.
Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

Share Price

₹ 244.4

-0.05 (-0.02%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Gujarat Themis Biosyn Ltd

1M

1Y

3Y

5Y

Monitoring Gujarat Themis Biosyn Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025244.4
20 Feb 2025244.45
19 Feb 2025251.5
18 Feb 2025212.2
17 Feb 2025229.75
14 Feb 2025249.15
13 Feb 2025260.5
12 Feb 2025263.7
11 Feb 2025263
10 Feb 2025274.35

SWOT Analysis Of Gujarat Themis Biosyn Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Gujarat Themis Biosyn Ltd

Asset Value vs Market Value of Gujarat Themis Biosyn Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Gujarat Themis Biosyn Ltd

No data available

No data available

Historical P/E Ratio of Gujarat Themis Biosyn Ltd

No data available

* All values are in %

Historical Revenue of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical EBITDA of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Net Profit of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Gujarat Themis Biosyn Ltd

No data available

* All values are in

About Gujarat Themis Biosyn Ltd

  • Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
  • It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

Gujarat Themis Biosyn Ltd News Hub

Gujarat Themis Biosyn standalone net profit declines 15.71% in the September 2024 quarter

Net profit of Gujarat Themis Biosyn declined 15.71% to Rs 10.57 crore in the quarter ended September

Read more

25 Oct 24

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 October 202

Read more

19 Oct 24

Board approved merger of Gujarat Themis Biosyn with Themis Medicare

The Board of Directors of Gujarat Themis Biosyn (GTBL) and Themis Medicare (TML) have approved a Sch

Read more

19 Nov 24

Gujarat Themis Biosyn standalone net profit declines 0.31% in the December 2024 quarter

Net profit of Gujarat Themis Biosyn declined 0.31% to Rs 12.97 crore in the quarter ended December 2

Read more

14 Feb 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Gujarat Themis Biosyn Ltd Market Cap

What is the market cap of Gujarat Themis Biosyn Ltd?

As of February 22, 2025, Gujarat Themis Biosyn Ltd has a market capitalization of ₹2663.11, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Gujarat Themis Biosyn Ltd's market capitalization?

Gujarat Themis Biosyn Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Gujarat Themis Biosyn Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Gujarat Themis Biosyn Ltd's market capitalization change?

Gujarat Themis Biosyn Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions